Admission Date:  [**2162-5-13**]              Discharge Date:   [**2162-5-17**]

Date of Birth:  [**2144-2-8**]             Sex:   F

Service: MEDICINE

Allergies:
No Known Allergies / Adverse Drug Reactions

Attending:[**First Name3 (LF) 1973**]
Chief Complaint:
Medication overdose (lithium, thorazine, atenolol)

Major Surgical or Invasive Procedure:
None


History of Present Illness:
18-year-old female with significant psychiatric history
presenting s/p overdose on lithium, thorazine, and atenolol. She
was in a verbal altercation with her mother on day of
presentation regarding a friend who her mother felt was a poor
influence. During this argument, pt was becoming agitated and
mother was calling her crisis counselor. In order to retaliate,
pt proceeded to take all of the pills left in her pill bottles,
including 48 pills of lithium 300mg, 10 pills of atenolol 25mg,
10 pills of thorazine 50mg, and 12 pills of thorazine 100mg.
Prior to this, she had been taking all medications as prescribed
and denies illicit drug or alcohol use. Pt states that this was
not a suicide attempt.
Her mother called EMS, and she was taken to [**Hospital3 **] ED.
At [**Hospital3 **] ED, initial vitals were: 98.5 119/79 95 14
99%RA. Toxicology consult was obtained. She was given 50grams
charcoal, polyethylene glycol. Lithium level was 3. WBC 17.7,
Hct 37.7, plts 400. She was then transferred to [**Hospital1 18**] ED for
further evaluation, including possible need for dialysis.
.
In the ED, initial VS were: 89 114/72 16 100%. Lithium level was
3.3. She was given 2L NS. Toxicology and renal were consulted.
They recommended q1-2 lithium/Cr checks with initiation of
dialysis if lithium levels rose above 4, q1h EKG and fingerstick
checks. She remained hemodynamically stable at ED with no focal
neurologic deficits and no concerns for mental status changes.
.
Review of systems:
(+) Per HPI; reports rhinorrhea, cough
(-) Denies fever, chills. Denies headache, sinus tenderness.
Denies shortness of breath, or wheezing. Denies chest pain,
chest pressure, palpitations, or weakness. Denies nausea,
vomiting, diarrhea, constipation, abdominal pain, or changes in
bowel habits. Denies dysuria, frequency, or urgency.

Past Medical History:
Anxiety
Bipolar disorder
PTSD
Asthma

Social History:
She is [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 1573**] in high school. She had been living in a group
home until 2.5 weeks ago. Since then she has been living with
her mother. Denies smoking or alcohol. Reports hx of marijuana
use, last use one year ago.

Family History:
Mother: anxiety, depression, fibromyalgia

Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: T 98.5 P 95 BP 119/79 RR 14 O2Sat 99%RA
General: Alert, oriented x 3, no acute distress
HEENT: Sclera anicteric, MMM, mouth and tongue covered with
black film from charcoal, oropharynx clear, EOMI, pupils dilated
and equal, reactive to light
Neck: supple, JVP not elevated, no LAD
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
ronchi
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no organomegaly
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro: CNII-XII intact
.
DISCHARGE PHYSICAL EXAM:
VS: Tm98.7 Tc98.0 P87(85-108) BP125/71(118-130/66-80) RR20
O2Sat97-99%RA
General: Alert, oriented x 3, no acute distress
HEENT: Sclera anicteric, MMM, mouth and tongue covered with
black film from charcoal, oropharynx clear, EOMI, pupils dilated
and equal, reactive to light
Neck: supple, JVP not elevated, no LAD
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,
gallops
Lungs: Clear to auscultation bilaterally, no wheezes, rales,
ronchi
Abdomen: soft, non-tender, non-distended, bowel sounds present,
no organomegaly
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or
edema
Neuro: CNII-XII intact

Pertinent Results:
ADMISSION LABS:
[**2162-5-13**] 09:15PM BLOOD WBC-13.2* RBC-3.96* Hgb-11.9* Hct-35.9*
MCV-91 MCH-30.0 MCHC-33.1 RDW-11.9 Plt Ct-393
[**2162-5-13**] 09:15PM BLOOD Neuts-73.0* Lymphs-20.6 Monos-3.2 Eos-3.0
Baso-0.3
[**2162-5-13**] 09:15PM BLOOD PT-11.3 PTT-24.1* INR(PT)-1.0
[**2162-5-13**] 09:15PM BLOOD Glucose-93 UreaN-9 Creat-0.8 Na-140 K-3.7
Cl-107 HCO3-22 AnGap-15
[**2162-5-13**] 09:15PM BLOOD HCG-<5
[**2162-5-13**] 09:15PM BLOOD Lithium-3.3*
[**2162-5-13**] 09:15PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
[**2162-5-13**] 09:20PM BLOOD Lactate-1.8
.
MICROBIOLOGY DATA:
[**2162-5-14**] 12:22 am MRSA SCREEN
**FINAL REPORT [**2162-5-16**]**
   MRSA SCREEN (Final [**2162-5-16**]):    No MRSA isolated.
.
RADIOLOGICAL STUDIES:
NONE
.
DISCHARGE LABS:
[**2162-5-16**] 05:35AM BLOOD WBC-10.0 RBC-4.33 Hgb-12.6 Hct-40.1
MCV-93 MCH-29.1 MCHC-31.3 RDW-12.1 Plt Ct-423
[**2162-5-16**] 05:35AM BLOOD Glucose-78 UreaN-6 Creat-0.7 Na-139 K-4.4
Cl-106 HCO3-22 AnGap-15
[**2162-5-16**] 05:35AM BLOOD ALT-24 AST-26 AlkPhos-101
[**2162-5-16**] 05:35AM BLOOD Calcium-9.6 Phos-4.4 Mg-1.8
[**2162-5-15**] 04:18AM BLOOD Lithium-1.2
.
PENDING LABS:
NONE

Brief Hospital Course:
Patient is a 18-year-old female with significant psychiatric
history presenting after overdose on lithium, thorazine, and
atenolol.

# Suicidal Ingestion with Lithium, throazine, atenolol:
Patient was initially taken to an outside hospital emergency
department, where she receieved activated charcoal and
Polyethylene Glycol.  She was then transferred to [**Hospital1 18**] for
consideration for hemodialysis given patient's lithium overdose.
 Patient was evaluated in the emergency department and then
admitted to the medical ICU.  Toxicology and nephrology were
consulted and the medical team monitored patient closely for
signs and symptoms of drug toxicity.  Over the course in the
medical ICU, lithium level in patient's blood decreased from a
supratherapeutic level of 3.3 to a therapeutic level of 1.2.
Patient continued to show no signs or symptoms of medication
toxicity evident on physical exam, vital signs, and EKG. After
stabilization, patient was transferred to a regular inpatient
medicine floor, where she continued to be asymptomatic and
medically stable. She was monitored with 1:1 sitter for
suicidality. She was transferred to inpatient psychiatry.

# Transitional Issues:
1) Psychiatric evaluation
2) Restart psychiatric medications

Medications on Admission:
Preadmission medications listed are correct and complete.
Information was obtained from PatientPharmacy.
1. guanFACINE *NF* 1 mg Oral at noon
2. ChlorproMAZINE 50 mg PO QAM
3. ChlorproMAZINE 100 mg PO QHS
4. Lithium Carbonate 600 mg PO BID
5. Atenolol 25 mg PO DAILY
6. Fluticasone Propionate 110mcg 2 PUFF IH QHS
7. Clonazepam 0.25 mg PO BID


Discharge Medications:
1. Fluticasone Propionate 110mcg 2 PUFF IH DAILY
2. ChlorproMAZINE 50 mg PO QAM:PRN agitation
3. ChlorproMAZINE 100 mg PO QHS:PRN agitation

Discharge Disposition:
Extended Care

Facility:
[**Hospital3 8063**] - [**Location (un) **]

Discharge Diagnosis:
PRIMARY DIAGNOSES:
1) Lithium overdose
2) Thorazine overdose
3) Atenolol overdose
.
SECONDARY DIAGNOSES:
1) Asthma
2) Anxiety NOS


Discharge Condition:
Alert and oriented to time, place, person.
Independently ambulatory.
Stable and asymptomatic.


Discharge Instructions:
You were admitted to the hospital after ingesting excessive
doses of lithium, thorazine, and atenolol.  Before you arrived
at [**Hospital1 18**], you receieved activated charcoal and GoLYTELY at
another hospital emergency room.  Then, you were transferred to
[**Hospital1 18**] where you were evaluated in the emergency department and
then admitted to the medical ICU.  While you were in the medical
ICU, specialists from toxicology and nephrology were consulted
and the medical team monitored you closely for signs and
symptoms of drug toxicity.  Over the course in the medical ICU,
lithium level in your blood decreased to therapeutic level and
you continued to show no signs or symptoms of medication
toxicity. Afterwards, you were transferred to a regular
inpatient medicine floor, where you continued to be asymptomatic
and medically stable. Your home medications including
guanf